NEWS

NEWS

Total 102

62
Press Release A Study in Nature Communications Reports that NeoImmuneTech's NT-I7 Enhances CAR-T Cell Expansion, Persistence and Anti-tumor Activity
2022-06-15
61
Press Release NeoImmuneTech to Present at Upcoming BIO International Convention
2022-06-13
60
Press Release NeoImmuneTech’s Lead Asset NT-I7 (efineptakin alfa) Shows Preliminary Anticancer Activity in Combination with Check-Point Inhibitors
2022-06-07
59
News Update NeoImmuneTech to Present at Immuno-Oncology Summit Europe 2022
2022-05-19
58
News Update NeoImmuneTech Received U.S. FDA Clearance of IND Application for Phase II Study of NT-I7 and Pembrolizumab in Recurrent Glioblastoma
2022-05-11
57
Press Release NeoImmuneTech to Show Significant Advances on NT-I7 (efineptakin alfa) at 2022 ASCO Annual Meeting
2022-04-28
56
Press Release NeoImmuneTech Demonstrates NT-I7’s Broad Combination Potential with Immune Checkpoint Inhibitors and Immunocytokine at AACR 2022
2022-04-14
55
News Update NeoImmuneTech to Celebrate First Year of Trading at KOSDAQ
2022-03-16
54
Press Release NeoImmuneTech to Present Two Posters at American Association for Cancer Research Annual Meeting
2022-03-10
53
Press Release NeoImmuneTech to Present at Upcoming Business Conferences
2022-02-09

1 2 3 4 5 >>>